📰 Early Access Program News
Page 34 - Early Access Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Early Access Program. Real-time updates on events, politics, business and more.
May 9, 2022
- Zenocutuzumab clinical abstract selected for oral presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting- Company to host investor call on Sunday, June 5 at 6:00 p.m.
May 9, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 9, 2022
(2022-05-09 | NDAQ:MRUS) Merus Announces Financial Results for the First Quarter 2022 and Provides Business Update
May 4, 2022
Company Signs Development & Manufacturing Agreement with Safer Medical of Montana for Formulation, Pilot Batches, and Commercial Production of CBD Topical Spray for Pain ReductionSOUTH EASTON, MA / ACCESSWIRE
April 27, 2022
Strong Market Demand Fuels Company's Decision to Access Early Revenue Generating Opportunities for UST Processing of High Quality Nanoemulsions of Oil-Based Active Ingredients for Multiple Markets Ahead
April 27, 2022
GuruFocus Article or News written by ACCESSWIRE and the topic is about:
April 22, 2022
ZURICH, SWITZERLAND / ACCESSWIRE / April 22, 2022 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development
April 22, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
April 21, 2022
/PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and...
April 21, 2022
Solid sales growth in Q1 2022 Market access secured in Germany and in France Marketing authorization granted in Israel Results from Phase 2 program in anti-GBM published in Journal of American Society of Nephrology (JASN)